Ke Li

Corporate Officer/Principal presso Shenyang Sunshine Pharmaceuticals Co., Ltd.

56 anni

Health Technology

Consumer Services

Posizioni attive di Ke Li

Società	Posizione	Inizio	Fine
Shenyang Sunshine Pharmaceuticals Co., Ltd. Shenyang Sunshine Pharmaceuticals Co., Ltd. BiotechnologyHealth Technology Shenyang Sunshine Pharmaceutical Co., Ltd. engages in the development and production of biological products. It offers recombinant human erythropoietin, interferon alfa 2b, interleukin 2, and thrombopoietin injections. Its business activities include research and development, and manufacture of biochemical reagents, and pharmaceutical project investment advisory services. The company was founded on January 3, 1993 and is headquartered in Shenyang, China.	Corporate Officer/Principal	01/03/1993	-

Società	Posizione	Inizio	Fine
3SBIO INC.	Corporate Officer/Principal	01/01/1993	-

Jilin University	Undergraduate Degree
Liaoning University	Undergraduate Degree

Distribuzione geografica

Cina	4
Isole Cayman	2

Posizioni

Corporate Officer/Principal	2
Undergraduate Degree	2

Settori

Health Technology	3
Consumer Services	3

Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Società quotate in Borsa	1
3SBIO INC.	Health Technology

Aziende private	1
Shenyang Sunshine Pharmaceuticals Co., Ltd. Shenyang Sunshine Pharmaceuticals Co., Ltd. BiotechnologyHealth Technology Shenyang Sunshine Pharmaceutical Co., Ltd. engages in the development and production of biological products. It offers recombinant human erythropoietin, interferon alfa 2b, interleukin 2, and thrombopoietin injections. Its business activities include research and development, and manufacture of biochemical reagents, and pharmaceutical project investment advisory services. The company was founded on January 3, 1993 and is headquartered in Shenyang, China.	Health Technology

Aziende private

Health Technology